Filing Details

Accession Number:
0001209191-21-032078
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-12 13:00:00
Reporting Period:
2021-05-10
Accepted Time:
2021-05-12 16:51:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662774 Cortexyme Inc. CRTX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1770783 Casey Lynch C/O Cortexyme, Inc.
269 East Grand Ave.
South San Francisco CA 94080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-10 13,584 $33.75 995,190 No 4 S Indirect By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Common Stock Disposition 2021-05-10 9,918 $34.89 985,272 No 4 S Indirect By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Common Stock Disposition 2021-05-10 6,315 $35.81 978,957 No 4 S Indirect By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Common Stock Disposition 2021-05-10 183 $36.73 978,774 No 4 S Indirect By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By the Zachary and Casey Lynch Living Trust dated February 24, 2009
No 4 S Indirect By the Zachary and Casey Lynch Living Trust dated February 24, 2009
No 4 S Indirect By the Zachary and Casey Lynch Living Trust dated February 24, 2009
No 4 S Indirect By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 49,895 Direct
Common Stock 91,911 Indirect By The Casey C. Lynch 2019 Annuity Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 29, 2020 and amended on December 18, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.41 to $34.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. Casey C. Lynch is a trustee of the Zachary and Casey Lynch Living Trust dated February 24, 2009, and shares voting and dispositive power with one other trustee with respect to the shares held of record by the Zachary and Casey Lynch Living Trust dated February 24, 2009.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.41 to $35.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.44 to $36.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. Casey C. Lynch is the trustee of The Casey C. Lynch 2019 Annuity Trust, and holds sole voting and dispositive power with respect to the shares held of record by The Casey C. Lynch 2019 Annuity Trust.